BRTX- Biorestorative Therapies, Inc.

Name: Biorestorative Therapies, Inc. Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

Biorestorative Therapies, Inc. (BRTX) has 2 insiders with recent SEC Form 4 filings, including 22 buys and 0 sells. BRTX is classified in the Biotechnology industry within the Health Care sector.

Insider Ownership

Role	Insider	Shares	Value	30d
CEO	Alstodt Lance	187.5K	$34.9K	-
VP	Silva Francisco	171.4K	$31.9K	-

Activity

Buys and sells only

Transactions

10 filings · page 7

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
Mar 21, 2022	Broadrick Dale60	10% Owner	Buy	155,950	$5.09	$794,110.02	+9.4%	-14.2%	-27.2%
Jan 24, 2022	Alstodt Lance55	President, CEO, Cob	Buy	1,470	$3.40	$4,998.00	+0.9%	+16.5%	-10.4%
Jan 5, 2022	Alstodt Lance55	President, CEO, Cob	Buy	2,000	$3.85	$7,700.00	+1.3%	+47.4%	-28.2%
Dec 1, 2021	Alstodt Lance55	President, CEO, Cob	Buy	799	$5.50	$4,394.50	+0.5%	-2.1%	-42.5%
Nov 23, 2021	Alstodt Lance55	President, CEO, Cob	Buy	2,500	$6.00	$15,000.00	+1.6%	-15.3%	-56.7%
Nov 22, 2021	Alstodt Lance55	President, CEO, Cob	Buy	396	$6.31	$2,498.76	+0.3%	-18.2%	-52.9%
Nov 19, 2021	Silva Francisco48	VP Of Research And Development	Buy	4,000	$6.66	$26,626.00	+51.1%	-35.6%	-59.1%
Nov 16, 2021	Alstodt Lance55	President, CEO, Cob	Buy	4,500	$6.71	$30,201.00	+0.7%	-37.9%	-55.6%
Nov 16, 2021	Silva Francisco48	VP Of Research And Development	Buy	7,826	$6.73	$52,631.58	+204.2%	-37.9%	-55.6%
Jan 6, 2020	Broadrick Dale60	10% Owner	Buy	8,460,210	$0.01	$102,812.31	+85.3%	-	-

← PrevPage 7Next →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC